Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 288

1.

Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.

Gao F, Wang ZX, Men JL, Ren J, Wei MX.

Chin Med J (Engl). 2011 Jun;124(11):1731-4.

PMID:
21740787
2.

Polymorphisms and high on-aspirin platelet reactivity after off-pump coronary artery bypass grafting.

Wang Z, Gao F, Men J, Yang J, Modi P, Wei M.

Scand Cardiovasc J. 2013 Aug;47(4):194-9. doi: 10.3109/14017431.2013.800640. Epub 2013 May 31.

PMID:
23688183
3.

P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.

Bierend A, Rau T, Maas R, Schwedhelm E, Böger RH.

Br J Clin Pharmacol. 2008 Apr;65(4):540-7. Epub 2007 Nov 8.

4.

Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.

Faraday N, Becker DM, Yanek LR, Herrera-Galeano JE, Segal JB, Moy TF, Bray PF, Becker LC.

Am J Cardiol. 2006 Sep 15;98(6):774-9. Epub 2006 Jul 28.

PMID:
16950183
5.

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.

Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.

Circulation. 2007 Jun 26;115(25):3156-64. Epub 2007 Jun 11.

PMID:
17562955
6.
7.

Antiplatelet effect of aspirin in patients with coronary artery disease.

Grove EL.

Dan Med J. 2012 Sep;59(9):B4506. Review.

PMID:
22951204
8.

Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.

Frelinger AL 3rd, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD.

Circulation. 2006 Jun 27;113(25):2888-96. Epub 2006 Jun 19.

PMID:
16785341
9.

Genetic determinants of response to aspirin: appraisal of 4 candidate genes.

Lordkipanidzé M, Diodati JG, Palisaitis DA, Schampaert E, Turgeon J, Pharand C.

Thromb Res. 2011 Jul;128(1):47-53. doi: 10.1016/j.thromres.2011.02.019. Epub 2011 Mar 22.

PMID:
21429568
10.

The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.

DiChiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA, Bailon O, Singla A, Gurbel PA.

Diabetes. 2007 Dec;56(12):3014-9. Epub 2007 Sep 11.

11.

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.

Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P.

Clin Pharmacol Ther. 2006 Sep;80(3):264-74.

PMID:
16952493
12.

Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.

Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS.

Thromb Haemost. 2008 Jul;100(1):83-9. doi: 10.1160/TH07-10-0590.

PMID:
18612542
13.

Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.

Kar R, Meena A, Yadav BK, Yadav R, Kar SS, Saxena R.

Platelets. 2013;24(4):297-302. doi: 10.3109/09537104.2012.693992. Epub 2012 Jun 21.

PMID:
22721490
15.

Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.

Hedegaard SS, Hvas AM, Grove EL, Refsgaard J, Rocca B, Daví G, Kristensen SD.

Thromb Res. 2009 May;124(1):96-100. doi: 10.1016/j.thromres.2008.12.034. Epub 2009 Feb 11.

PMID:
19215971
16.

Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.

Platelets. 2011;22(3):188-95. doi: 10.3109/09537104.2010.543963. Epub 2011 Jan 13.

PMID:
21231857
17.

Aspirin resistance in off-pump coronary artery bypass grafting.

Wang Z, Gao F, Men J, Ren J, Modi P, Wei M.

Eur J Cardiothorac Surg. 2012 Jan;41(1):108-12. doi: 10.1016/j.ejcts.2011.04.021.

18.

Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.

Grove EL, Hvas AM, Mortensen SB, Larsen SB, Kristensen SD.

J Thromb Haemost. 2011 Jan;9(1):185-91. doi: 10.1111/j.1538-7836.2010.04115.x.

19.

Aspirin failure in patients presenting with acute cerebrovascular ischaemia.

Halawani SH, Williams DJ, Adefurin A, Webster J, Greaves M, Ford I.

Thromb Haemost. 2011 Aug;106(2):240-7. doi: 10.1160/TH11-01-0045. Epub 2011 May 5. Erratum in: Thromb Haemost. 2011 Dec;106(6):1234. Adefurin, Abiodun [added].

PMID:
21544317
20.

Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.

Liu T, Zhang J, Chen X, Feng X, Fu SW, McCaffrey TA, Liu M.

Gene. 2015 Oct 15;571(1):23-7. doi: 10.1016/j.gene.2015.06.045. Epub 2015 Jun 19.

PMID:
26095809

Supplemental Content

Support Center